Study ID: ABS-AS-302
Study Title
- Efficacy of Albuterol SPIROMAXֲ® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)
Teva Identifier
- ABS-AS-302
ClinicalTrials.gov Identifier
- NCT01791972
Study Status
- Completed
Trial Condition(s)
- Exercise-Induced Bronchoconstriction (EIB)
Interventions
- Drug: Albuterol Spiromax | Drug: Placebo Spiromax
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 50 Years
Trial Duration
- 03/01/2013 - 06/01/2013
Phase
- Phase 3
Study Type
Interventional
